COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI was delisted on the 3rd of September, 2025.
9 hedge funds and large institutions have $61.9K invested in COSCIENS Biopharma Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 7 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.4% less ownership
Funds ownership: 0.93% → 0.53% (-0.4%)
31% less funds holding
Funds holding: 13 → 9 (-4)
52% less capital invested
Capital invested by funds: $130K → $61.9K (-$67.7K)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$25.1K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$254 |
| 3 |
TC
Truvestments Capital
Sarasota,
Florida
|
+$112 |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$15 |
| 5 |
DB
Danske Bank
Copenhagen K,
Denmark
|
+$10 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$62.1K |
| 2 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$10.4K |
| 3 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$2.04K |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$809 |
CSCI Hedge Fund Activity: Q3 2024 in Review
9 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q3 2024, worth a combined $61.9K — down 52% from $130K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of CSCI and 3 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was National Bank of Canada, adding an estimated $25.1K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $62.1K sold.
- 9 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q3 2024, down from 13 in Q2 2024.
- Funds reported $61.9K of COSCIENS Biopharma Inc. Common Stock stock for Q3 2024, down 52% quarter-over-quarter.
- 3 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q3 2024 and 7 closed out, a net change of -4 holders.
- The largest COSCIENS Biopharma Inc. Common Stock buyer in Q3 2024 was National Bank of Canada, an estimated $25.1K added.
- The largest COSCIENS Biopharma Inc. Common Stock seller in Q3 2024 was Susquehanna International Group, an estimated $62.1K sold.
Based on aggregated 13F filings for Q3 2024.